Literature DB >> 29589044

[The role of innate immunity in otitis media].

M Wigand1, T K Hoffmann1, A F Ryan2, B Wollenberg3, A Leichtle4.   

Abstract

Otitis media (OM) belongs to the most common pediatric diseases and causes more medical contacts, surgical interventions, and drug prescriptions than any other infectious disease. Recent findings have identified a critical role of innate immunity in recovery from OM. The middle ear mucosa identifies invading pathogens by sensing pathogen-associated molecule patterns (PAMPs) via pattern recognition receptors such as the Toll-like receptors (TLRs). They generate immediate antimicrobial responses and cytokine release, leading to an inflammatory reaction as seen in acute or chronic OM. Cross-talk between TLRs can enhance or suppress the healing process in the middle ear. In order to prevent over-activation on the one hand and insufficient immune response on the other, the signaling network between different TLRs must be integrated and controlled by positive and negative feedback loops. This guarantees a proper immune response in the middle ear after infection. In this review, we focus on the involvement of the innate immune system and TLRs in OM, as well on their relevance for new vaccination strategies and immunotherapies.

Entities:  

Keywords:  Cytokines; Immunology; Infection; Middle ear; Toll-like receptors

Mesh:

Substances:

Year:  2018        PMID: 29589044     DOI: 10.1007/s00106-018-0501-x

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  57 in total

Review 1.  The Toll receptor family and microbial recognition.

Authors:  R Medzhitov; C Janeway
Journal:  Trends Microbiol       Date:  2000-10       Impact factor: 17.079

2.  Management of acute otitis media.

Authors:  S Forgie; G Zhanel; J Robinson
Journal:  Paediatr Child Health       Date:  2009-09       Impact factor: 2.253

3.  Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.

Authors:  Kevin S Gorski; Emily L Waller; Jacqueline Bjornton-Severson; John A Hanten; Christie L Riter; William C Kieper; Keith B Gorden; Jeffrey S Miller; John P Vasilakos; Mark A Tomai; Sefik S Alkan
Journal:  Int Immunol       Date:  2006-05-25       Impact factor: 4.823

4.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

5.  Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media.

Authors:  Takashi Hirano; Satoru Kodama; Keigo Fujita; Kazuhiko Maeda; Masashi Suzuki
Journal:  FEMS Immunol Med Microbiol       Date:  2007-02

6.  Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility.

Authors:  Irina Smirnova; Navjiwan Mann; Annemiek Dols; H H Derkx; Martin L Hibberd; Michael Levin; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media.

Authors:  Yu Si; Zhi Gang Zhang; Sui Jun Chen; Yi Qing Zheng; Yu Bin Chen; Yi Liu; Huaili Jiang; Lian Qiang Feng; Xi Huang
Journal:  Hum Immunol       Date:  2014-05-29       Impact factor: 2.850

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.

Authors:  Cheng-Lung Ku; Horst von Bernuth; Capucine Picard; Shen-Ying Zhang; Huey-Hsuan Chang; Kun Yang; Maya Chrabieh; Andrew C Issekutz; Coleen K Cunningham; John Gallin; Steven M Holland; Chaim Roifman; Stephan Ehl; Joanne Smart; Mimi Tang; Franck J Barrat; Ofer Levy; Douglas McDonald; Noorbibi K Day-Good; Richard Miller; Hidetoshi Takada; Toshiro Hara; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; David Speert; Damien Sanlaville; Xiaoxia Li; Frédéric Geissmann; Eric Vivier; László Maródi; Ben-Zion Garty; Helen Chapel; Carlos Rodriguez-Gallego; Xavier Bossuyt; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  1 in total

1.  Immunomodulation as a Protective Strategy in Chronic Otitis Media.

Authors:  Anke Leichtle; Arwa Kurabi; David Leffers; Markus Därr; Clara Sophia Draf; Allen Frederic Ryan; Karl-Ludwig Bruchhage
Journal:  Front Cell Infect Microbiol       Date:  2022-03-30       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.